Copyright © 2000 by the European Society of Cardiology.
Letter to the Editor
TNF-
system in CHF
a National Heart and Lung Institute, London, U.K.
b National Heart and Lung Institute, London, U.K.
References
- van Riemsdijk-van Overbeeke IC, Baan CC, Niesters HG. The TNF-alpha system in heart failure and after heart transplantation; plasma protein levels, mRNA expression, soluble receptors and plasma buffer capacity. Eur Heart J. 1999;20:833840
[Abstract/Free Full Text] - Ceconi C, Curello S, Bachetti T, Corti A, Ferrari R. Tumor necrosis factor in congestive heart failure: a mechanism of disease for the new millennium? Prog Cardiovasc Dis. 1998;41:2530[CrossRef][Web of Science][Medline]
- Niebauer J, Volk HD, Kemp M. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet. 1999;353:18381842[CrossRef][Web of Science][Medline]
- Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990;323:236241[Abstract]
- Dibbs Z, Thornby J, White BG, Mann DL. Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: implications for clinical trials. J Am Coll Cardiol. 1999;33:19351942
[Abstract/Free Full Text] - Anker SD, Ponikowski PP, Clark AL. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure. Eur Heart J. 1999;20:683693
[Abstract/Free Full Text] - Vanderheyden M, Kersschot E, Paulus WJ. Pro-inflammatory cytokines and endothelium-dependent vasodilation in the forearm. Serial assessment in patients with congestive heart failure. Eur Heart J. 1998;19:747752
[Abstract/Free Full Text]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||